Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inh... MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler. Show more
Conference Call to Begin Today at 4:30 p.m. (ET) 3Q 2024 Total revenues of $70M; +37% vs. 3Q 2023YTD 2024 Total revenues of $209M; +49% vs. YTD 2023YTD 2024 Net income of $20 million; Non-GAAP net...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of...
Met primary objective demonstrating nintedanib DPI was safe and well toleratedParticipants did not experience adverse events typically reported with oral nintedanibExpect to meet with the FDA in...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0189 | 0.272727272727 | 6.93 | 7.44 | 6.62 | 2884649 | 6.85627177 | CS |
| 4 | 0.4789 | 7.40185471406 | 6.47 | 7.63 | 6.305 | 2948924 | 7.03611884 | CS |
| 12 | 1.0589 | 17.9779286927 | 5.89 | 7.63 | 5.8 | 2409417 | 6.63863707 | CS |
| 26 | 2.2289 | 47.2224576271 | 4.72 | 7.63 | 4.36 | 2452180 | 5.88420231 | CS |
| 52 | 3.1789 | 84.3209549072 | 3.77 | 7.63 | 3.17 | 2612947 | 4.92777643 | CS |
| 156 | 2.1889 | 45.9852941176 | 4.76 | 7.63 | 2.49 | 3310441 | 4.30324882 | CS |
| 260 | 5.7489 | 479.075 | 1.2 | 7.63 | 0.8 | 3345680 | 3.83601282 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
